Eduardo Martin Moraud

Expertise The Moraud group develops closed-loop neuromodulation therapies for movement disorders, particularly Parkinson’s disease, with a specific emphasis on gait and balance impairments. The group integrates multimodal monitoring of motor and neural biomarkers to enable real-time decoding of dysfunctional states and their underlying neural dynamics, advancing a circuit-level understanding of locomotor control and informing the design of state-dependent adaptive therapies. Mission The group aims to translate mechanistic insights into clinically viable, personalized neuromodulation strategies to improve mobility and quality of life for patients with neurological disorders. Eduardo M. Moraud studied electrical and control engineering in Spain (UPM Madrid) and France (École des Mines de Paris), and obtained an MSc in Artificial Intelligence from the University of Edinburgh. After gaining experience in robotics and AI in Japan (ATR), France (INRIA), and the Netherlands (ESA), he completed his PhD in Neural Engineering at ETH Zurich, for which he was finalist for the best doctoral thesis award from the Swiss Society for Biomedical Engineering. He then pursued postdoctoral research at the University of Oxford, focusing on neural biomarkers for closed-loop deep brain stimulation. He subsequently joined the Department of Neurosurgery at CHUV as a junior principal investigator, supported by EU (Marie Skłodowska-Curie) and SNSF (Ambizione and Starting Grant) fellowships. At CHUV, he developed a translational research program on closed-loop neuromodulation for gait and balance deficits in Parkinson’s disease, and was selected as a finalist in the Life Sciences Switzerland (LS²) "PIs of Tomorrow" call. He joined Neuro-X at EPFL in January 2026. His current research is supported by the Swiss National Science Foundation, the Michael J. Fox Foundation, the U.S. Department of Defense, and Parkinson Switzerland, among others. Teaching & PhD PhD Students Ruijia Wang, Paula Sanchez Lopez